[Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
An examination of 80 patients with ischaemic cerebrovascular disease, subdivided into 5 groups according to platelet antiaggregant treatment, demonstrated the insufficient effectiveness of acetylsalicylic acid in preventing recurrences. The drug failure can most probably be attributed to its particular action mechanism or to dosage.
D000328:Adult; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002546:Ischemic Attack, Transient / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D011897:Random Allocation; D013997:Time Factors
D001241:Aspirin
L'acido acetil-salicilico nella terapia delle vasculopatie cerebrali ischemiche.